| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 04/30/2008 | EP1716118B1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases |
| 04/30/2008 | CN101168525A Method for preparing caprolactam |
| 04/30/2008 | CN101168524A Method for preparing low sulfonated caprolactam |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | CN100383125C Method for transforming to epsi-caprolactam O-alkyl-epsi-caprolactim |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361652 βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/22/2008 | US7361651 Procoralan; brandycardial agent: angina pectoris, myocardial infarct, heart failure, myocardial ischaemia, supraventricular rhythm disturbances; stability and processability |
| 04/22/2008 | US7361650 γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/22/2008 | US7361649 β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/17/2008 | WO2008011539A3 Anesthetic compounds |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/16/2008 | EP1910321A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358357 Feeding oleum and cyclohexanone oxime into a first reaction mixture comprising caprolactam, sulfuric acid and SO3,feeding a portion of the first reaction mixture and cyclohexanone oxime into a second reaction mixture comprising caprolactam, sulfuric acid and SO3, withdrawing |
| 04/15/2008 | US7358240 excellent purity; bradycardic agent; myocardial ischaemia: angina pectoris, myocardial infarct, arrhythmia disturbances, heart failure; structure confirms by X-ray diffraction data; industrial scale, storage stability |
| 04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/09/2008 | CN101157646A Method for producing monomer aminocaprolactam by using nylon 6 waste and old material |
| 04/09/2008 | CN100379726C Process for producing epsilon-hexanolactam |
| 04/08/2008 | US7354914 1-[3-Methyl-1-(5-methyl-6-oxo-benzo[b]-1,4-oxazepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome |
| 04/08/2008 | CA2203183C Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef][2]benzazepine |
| 04/03/2008 | WO2008038578A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME |
| 04/03/2008 | WO2008038053A1 Ion channel modulators & uses thereof |
| 04/02/2008 | EP1904069A2 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 04/01/2008 | CA2298974C Thiazolobenzoheterocycles, preparation and medicines containing same |
| 03/27/2008 | WO2007115943A3 Process for the preparation of an n-alkyl lactam with improved colour quality |
| 03/27/2008 | US20080076752 substituted structure of 3-amino-2-(2,5-difluorophenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one; 6-amino-7-phenyl-1,4-thiazepan-5-one; -amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one for treating neurological disorders such as Alzheimer's; inhibit the production of amyloid beta protein |
| 03/27/2008 | US20080074045 Organic electroluminescence device |
| 03/26/2008 | EP1903032A1 Method for purifying lactams |
| 03/26/2008 | EP1902717A2 Vasopressin antagonist and oxytocin antagonist |
| 03/26/2008 | EP1901752A2 Compositions and methods for viral inhibition |
| 03/20/2008 | WO2007080131A3 Anthranilamide derivatives and their use for the control of insects and acari |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/19/2008 | EP1603651A4 Distillative method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine |
| 03/19/2008 | CN101146812A Optically active ammonium salt compound, production intermediate thereof and method for producing same |
| 03/19/2008 | CN101143843A Method for preparing epsilon-caprolactam |
| 03/19/2008 | CN100375741C Process for producing lactam |
| 03/18/2008 | US7345032 alkylation of 1,3-diaminopropane or addition to diethyl vinylphosphonate, to form N-(3-aminopropyl)aminoethanephosphonic acid diethyl ester, which is condensed with a squarate compound to give drugs used as N-methyl-D-aspartic acid (NMDA) antagonists |
| 03/18/2008 | CA2256379C Substance mixtures comprising vinyl-containing compounds and stabilizers |
| 03/13/2008 | WO2007146838A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 03/13/2008 | US20080064871 Production Method of Nitrogen-Containing Fused Ring Compounds |
| 03/12/2008 | EP1896036A1 Anti-inflammatory agents |
| 03/12/2008 | EP1763515B1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 03/12/2008 | CN101142191A Process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide |
| 03/12/2008 | CN101142179A Process for making caprolactam |
| 03/12/2008 | CN101142178A Improved method for making caprolactam from impure 6-aminocapronitrile |
| 03/12/2008 | CN100374418C Synthesis of caprolactam and its oligomer |
| 03/11/2008 | US7342008 Containing a benzodiazepine ring; 2-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; Alzheimer's disease and Down's Syndrome; prevent the formation of neurological deposits of amyloid protein |
| 03/11/2008 | US7342007 prevent the formation of neurological deposits of amyloid protein; Alzheimer's disease, cognitive impairment; novel lactarns; N2-[(3,5-difluorophenyl)acetyl]-N1-[(3S,7S)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide; secretase inhibitors |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/05/2008 | CN100372840C Intermediate for the preparation of epimino |
| 03/05/2008 | CN100372835C Method for purifying lactams |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/28/2008 | WO2008022945A1 Aryl sulfonamides with an analgesic action |
| 02/28/2008 | CA2663598A1 New compounds |
| 02/27/2008 | EP1891014A2 Improved process for crystallization of benazepril hydrochloride |
| 02/27/2008 | CN101130514A Intermediate for the preparation of epimino |
| 02/27/2008 | CN101130167A Catalyzer for one-step synthesis of caprolactam |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/21/2008 | WO2008019572A1 Meptazinol biligand derivatives and/or their salts, preparation method and uses thereof |
| 02/21/2008 | US20080045502 Processes for Preparing 3-Benzazepines |
| 02/21/2008 | US20080045500 Nerve Regeneration Stimulator |
| 02/21/2008 | US20080045499 Preferential Inhibition of Presenilin-1 |
| 02/21/2008 | US20080045497 Substituted aniline derivatives |
| 02/21/2008 | DE102006039003A1 Neue Verbindungen New connections |
| 02/20/2008 | CN101128422A Lactam production method |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/14/2008 | US20080039444 Antiallergens; antiinflammatory agents; rhinitis |
| 02/13/2008 | EP1885699A1 Crystalline form of benzazepinium maleate derivative |
| 02/13/2008 | CN100368396C Method for making caprolactam |
| 02/07/2008 | WO2006105304A8 Phenyl and pyridyl lta4h modulators |
| 02/06/2008 | CN101117327A Preparation method of aminocaprolactam |
| 02/06/2008 | CN101117326A Method for preparing aminocaprolactam by catalysis of nicotinic acid in ionic liquid |
| 02/06/2008 | CN100366613C Method for preparation of (s)-(+)-and(r)-(-)10,11-dihydro-10-hydrodoxy-5h-dibenz/b,f/azephine-5-carboxamide |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326698 Prostaglandin analogs |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 01/31/2008 | WO2008012837A1 Process for producing 10-oxo-l10, 11-dihydr0-5h-dibenz [b, f] azepine-5-carboxamide starting from 5-cyanoiminostilbene |
| 01/31/2008 | WO2008012524A1 Substituted aniline derivatives |
| 01/31/2008 | US20080027041 Pyridizinone derivatives |
| 01/31/2008 | US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | CA2658913A1 Substituted aniline derivatives |
| 01/31/2008 | CA2658675A1 Process for producing 10-oxo-10, 11-dihydr0-5h-dibenz [b, f] azepine-5-carboxamide starting from 5-cyanoiminostilbene |
| 01/24/2008 | WO2008011539A2 Anesthetic compounds |
| 01/24/2008 | WO2008009671A1 Process for the preparation of a tetrahydro-1h-azepines |
| 01/24/2008 | US20080021014 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 01/24/2008 | CA2656510A1 Anesthetic compounds |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |